- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IRLAB Therapeutics AB (IRLABa)IRLAB Therapeutics AB stock price live, this page displays ST IRLABa stock exchange data. View the IRLABa premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IRLAB Therapeutics AB real time stock price chart below.
What Is the IRLAB Therapeutics AB Stock Price Today?
The IRLAB Therapeutics AB stock price today is 11.950.
What Is the Stock Symbol for IRLAB Therapeutics AB?
The stock ticker symbol for IRLAB Therapeutics AB is IRLABa.
Is IRLABa the Same as $IRLABa?
$IRLABa is a common way to refer to the IRLAB Therapeutics AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does IRLAB Therapeutics AB Trade On?
IRLAB Therapeutics AB is listed and trades on the Stockholm stock exchange.
Is IRLAB Therapeutics AB a Good Stock to Buy?
Determining whether IRLAB Therapeutics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current IRLAB Therapeutics AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRLABa quote. (ISIN: SE0012675361)
What Is the IRLAB Therapeutics AB Stock Price Today?
The IRLAB Therapeutics AB stock price today is 11.950.
What Is the Stock Symbol for IRLAB Therapeutics AB?
The stock ticker symbol for IRLAB Therapeutics AB is IRLABa.
Is IRLABa the Same as $IRLABa?
$IRLABa is a common way to refer to the IRLAB Therapeutics AB ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does IRLAB Therapeutics AB Trade On?
IRLAB Therapeutics AB is listed and trades on the Stockholm stock exchange.
Is IRLAB Therapeutics AB a Good Stock to Buy?
Determining whether IRLAB Therapeutics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current IRLAB Therapeutics AB share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRLABa quote. (ISIN: SE0012675361)
Stockholm
Currency in SEK
11.950
-0.100(-0.83%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.200
12.000
52 wk Range
5.600
20.200
IRLABa Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.20012.000
52 wk Range
5.60020.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRLABa Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
IRLAB Therapeutics AB Company Profile
IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson’s disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 research programs for the treatment of neurodegenerative disorders and ageing; IRL1117, a drug candidate developed for once-daily oral treatment for the hallmark symptoms of Parkinson’s; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson’s disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is headquartered in Gothenburg, Sweden.
Compare IRLABa to Peers and Sector
Metrics to compare | IRLABa | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRLABaPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.5x | −4.9x | −0.7x | |
PEG Ratio | −0.15 | −0.11 | 0.00 | |
Price / Book | 16.4x | 3.3x | 2.6x | |
Price / LTM Sales | 12.3x | 15.0x | 3.2x | |
Upside (Analyst Target) | 263.6% | 75.0% | 47.1% | |
Fair Value Upside | Unlock | 8.1% | 7.3% | Unlock |
FAQ
What Is the IRLAB Therapeutics (IRLABa) Stock Price Today?
The IRLAB Therapeutics stock price today is 11.95
What Stock Exchange Does IRLAB Therapeutics Trade On?
IRLAB Therapeutics is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for IRLAB Therapeutics?
The stock symbol for IRLAB Therapeutics is "IRLABa."
What Is the IRLAB Therapeutics Market Cap?
As of today, IRLAB Therapeutics market cap is 617.23M.
What is IRLAB Therapeutics Earnings Per Share?
The IRLAB Therapeutics EPS is -2.17.
What Is the Next IRLAB Therapeutics Earnings Date?
IRLAB Therapeutics will release its next earnings report on Feb 12, 2025.
From a Technical Analysis Perspective, Is IRLABa a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.